Drug Shortage Report for TOBRAMYCIN INJECTION

Last updated on 2019-01-09 History
Report ID 66481
Drug Identification Number 02230640
Brand name TOBRAMYCIN INJECTION
Common or Proper name Tobramycin for Injection
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) TOBRAMYCIN
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 2 mL
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-11-26
Actual start date
Estimated end date
Actual end date 2019-01-08
Shortage status Resolved
Updated date 2019-01-09
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of Tobramycin for Injection 40 mg/mL MD Vial 2 mL will be available at all distribution centers effective Tuesday, January 8, 2019
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-01-09 English Compare
v9 2019-01-04 French Compare
v8 2019-01-04 English Compare
v7 2019-01-04 English Compare
v6 2018-12-24 French Compare
v5 2018-12-24 English Compare
v4 2018-11-27 English Compare
v3 2018-11-08 French Compare
v2 2018-11-08 English Compare
v1 2018-11-08 English Compare